Amphastar Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, Needham downgraded the stock from Buy to Hold.

Benzinga Newsdesk www.benzinga.com Negative 96.3%

Neg 96.3% Neu 0% Pos 0%

Comments

No comments yet. Be the first!